EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 225 filers reported holding EMERGENT BIOSOLUTIONS INC in Q2 2016. The put-call ratio across all filers is 4.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $615,000 | -10.0% | 10,369 | 0.0% | 0.12% | +7.0% |
| Q3 2018 | $683,000 | +30.3% | 10,369 | 0.0% | 0.12% | +19.8% |
| Q2 2018 | $524,000 | -4.0% | 10,369 | 0.0% | 0.10% | -6.8% |
| Q1 2018 | $546,000 | +13.3% | 10,369 | 0.0% | 0.10% | +15.7% |
| Q4 2017 | $482,000 | -8.4% | 10,369 | -20.3% | 0.09% | -11.0% |
| Q3 2017 | $526,000 | -32.4% | 13,012 | -43.3% | 0.10% | -34.2% |
| Q2 2017 | $778,000 | +16.8% | 22,929 | 0.0% | 0.15% | +13.4% |
| Q1 2017 | $666,000 | -26.3% | 22,929 | -16.7% | 0.13% | -26.8% |
| Q4 2016 | $904,000 | -13.5% | 27,531 | -16.9% | 0.18% | -14.5% |
| Q3 2016 | $1,045,000 | +68.8% | 33,137 | +50.5% | 0.21% | +67.2% |
| Q2 2016 | $619,000 | -22.6% | 22,017 | +0.0% | 0.13% | -23.8% |
| Q1 2016 | $800,000 | -9.2% | 22,016 | 0.0% | 0.17% | -13.4% |
| Q4 2015 | $881,000 | +40.5% | 22,016 | 0.0% | 0.19% | +35.7% |
| Q3 2015 | $627,000 | – | 22,016 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
| Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
| AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
| Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
| Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
| SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
| EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
| PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |